Back to Agenda
New Medical Device Regulations in the EU
Session Chair(s)
John Wilkinson
Director of Devices, MHRA, United Kingdom
This session will focus on the new EU Medical Device Regulation. Updates on legislative process, expectations and content and implementation of the upcoming changes will be extensively discussed. After this session, you will be up to date on the latest developments around this very important regulation and its implications across the medtech sector. The session will include an interactive panel, in which the panelist will share their insights on any questions you might have.
Speaker(s)
Perspective of a Member State
Matthias Neumann
, Federal Ministry of Health (BMG), Germany
Changing Role of Notified Bodies
Gert Bos, PhD, MSc
Chief Scientific Oficer, Executive Director, Partner, Qserve Group B.V., Netherlands
Impact on Industry
Peter Schroeer, RAC
Senior Director, Regulatory Policy Innovation, Johnson & Johnson, Germany
Panel Discussion
Reinhard Berger, DRSc, MSc
Regulatory Affairs Medical Devices, Consulting-Advising, Austria
Panel Discussion
Sabina Hoekstra-van den Bosch, PharmD, MSc, RPh
Global Director Regulatory Strategy, Tüv Süd, Netherlands
Have an account?